U.S. pharma large copyright scrapped two experimental weight loss pills very last calendar year—a at the time-day-to-day capsule, lotiglipron, because of elevated liver enzymes plus a 2 times-daily pill, danuglipron, due to powerful side effects—but CEO Albert Bourla has stated the company is set to “Participate in and earn” in the being ov